Evergreen Capital Management LLC Has $1.58 Million Stock Position in HCA Healthcare, Inc. $HCA

Evergreen Capital Management LLC lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 129.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,379 shares of the company’s stock after purchasing an additional 1,907 shares during the quarter. Evergreen Capital Management LLC’s holdings in HCA Healthcare were worth $1,578,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth about $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare during the 4th quarter worth about $29,000. Harbor Capital Advisors Inc. boosted its position in HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after acquiring an additional 34 shares during the period. JPL Wealth Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth about $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in HCA Healthcare during the 4th quarter worth about $34,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 0.6%

HCA opened at $474.34 on Friday. HCA Healthcare, Inc. has a 12-month low of $321.39 and a 12-month high of $556.52. The firm has a market capitalization of $106.05 billion, a P/E ratio of 16.71, a price-to-earnings-growth ratio of 1.45 and a beta of 1.36. The stock’s 50 day moving average price is $507.59 and its two-hundred day moving average price is $485.06.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter last year, the firm earned $6.22 EPS. HCA Healthcare’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 30.17 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is 10.99%.

Wall Street Analyst Weigh In

A number of brokerages have commented on HCA. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research report on Friday, March 27th. Wall Street Zen downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Jefferies Financial Group raised their price target on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Truist Financial raised their price target on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $537.36.

Insider Transactions at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 15,214 shares of company stock worth $7,797,595 over the last quarter. 1.50% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.